• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.

作者信息

Moll Matthew, Zon Rebecca L, Sylvester Katelyn W, Rimsans Jessica, Chen Evan C, Ghosh Auyon J, Abston Eric, Kim Andy, Rutherford Henry, Mitre Xhoi, Hakim Aaron, Connell Nathan T, Battinelli Elisabeth, Fredenburgh Laura E, Baron Rebecca M, Hobbs Brian D, Cho Michael H, Mittleman Murray A, Woolley Ann E, Connors Jean M

机构信息

Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

出版信息

Thromb Res. 2021 Jul;203:57-60. doi: 10.1016/j.thromres.2021.04.009. Epub 2021 Apr 19.

DOI:10.1016/j.thromres.2021.04.009
PMID:33940309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8053596/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/8053596/cc9a67b882a0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/8053596/cc9a67b882a0/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/998f/8053596/cc9a67b882a0/gr1_lrg.jpg

相似文献

1
Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis.新冠重症监护病房患者中，中等剂量与标准剂量肝素预防的倾向性评分匹配分析
Thromb Res. 2021 Jul;203:57-60. doi: 10.1016/j.thromres.2021.04.009. Epub 2021 Apr 19.
2
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病：治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验)：一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
3
Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit.重症监护病房中感染 SARS-CoV2 的患者的肝素剂量、水平和耐药性。
Int J Lab Hematol. 2021 Dec;43(6):1284-1290. doi: 10.1111/ijlh.13543. Epub 2021 Apr 14.
4
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.COVID-19 住院高危患者中治疗剂量肝素与标准预防剂量或中剂量肝素预防血栓的疗效和安全性：HEP-COVID 随机临床试验。
JAMA Intern Med. 2021 Dec 1;181(12):1612-1620. doi: 10.1001/jamainternmed.2021.6203.
5
Heparin resistance in COVID-19 patients in the intensive care unit.COVID-19 患者在重症监护病房中肝素耐药。
J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0.
6
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial.重症 COVID-19 患者中阿托伐他汀与安慰剂的对比：随机对照试验。
BMJ. 2022 Jan 7;376:e068407. doi: 10.1136/bmj-2021-068407.
7
Association of anticoagulation dose and survival in hospitalized COVID-19 patients: A retrospective propensity score-weighted analysis.COVID-19 住院患者抗凝剂量与生存的相关性：一项回顾性倾向评分加权分析。
Eur J Haematol. 2021 Feb;106(2):165-174. doi: 10.1111/ejh.13533. Epub 2020 Nov 4.
8
An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients.一项针对危重症 COVID-19 患者中、高剂量血栓预防的观察性研究。
Acta Anaesthesiol Scand. 2022 Mar;66(3):365-374. doi: 10.1111/aas.14013. Epub 2021 Dec 16.
9
Outcomes of non-COVID-19 critically ill patients during the COVID-19 pandemic : A retrospective propensity score-matched analysis.COVID-19 大流行期间非 COVID-19 危重症患者的结局：一项回顾性倾向评分匹配分析。
Wien Klin Wochenschr. 2021 Sep;133(17-18):942-950. doi: 10.1007/s00508-021-01857-4. Epub 2021 Apr 19.
10
Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.评价 COVID-19 重症患者低剂量阿司匹林的使用：一项多中心倾向评分匹配研究。
J Intensive Care Med. 2022 Sep;37(9):1238-1249. doi: 10.1177/08850666221093229. Epub 2022 Apr 21.

引用本文的文献

1
The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants.新冠病毒病的最佳抗凝策略：预防性还是治疗性？：对超过27000名参与者的荟萃分析、试验序贯分析和荟萃回归分析
Emerg Crit Care Med. 2022 Sep;2(3):148-166. doi: 10.1097/EC9.0000000000000059. Epub 2022 Sep 16.
2
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis.两种肝素方案预防 COVID-19 住院患者静脉血栓栓塞症的疗效和安全性：一项荟萃分析。
Intern Emerg Med. 2023 Apr;18(3):863-877. doi: 10.1007/s11739-022-03159-7. Epub 2022 Dec 29.
3

本文引用的文献

1
Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.COVID-19 第二波和第一波住院患者的血栓并发症发生率和总生存率。
Thromb Res. 2021 Mar;199:143-148. doi: 10.1016/j.thromres.2020.12.019. Epub 2020 Dec 30.
2
Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.COVID-19 肺炎危重症患者高剂量预防性抗凝的影响。
Chest. 2021 Jun;159(6):2417-2427. doi: 10.1016/j.chest.2021.01.017. Epub 2021 Jan 16.
3
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
SARS-CoV-2 gamma variant and chronic arterial insufficiency due to late arterial thrombosis.
严重急性呼吸综合征冠状病毒2型伽马变异株与晚期动脉血栓形成所致的慢性动脉供血不足
Int J Health Sci (Qassim). 2022 Jul-Aug;16(4):70-72.
4
Impact of Thromboprophylaxis Intensity on Patients' Mortality Among Hospitalized Patients with COVID-19: A Propensity-Score Matched Study.血栓预防强度对COVID-19住院患者死亡率的影响：一项倾向评分匹配研究
Clin Epidemiol. 2022 Mar 19;14:361-368. doi: 10.2147/CLEP.S359132. eCollection 2022.
5
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis.住院COVID-19患者凝血功能障碍的中度至治疗性抗凝与预防性抗凝：一项系统评价和荟萃分析。
Thromb J. 2021 Nov 24;19(1):91. doi: 10.1186/s12959-021-00343-1.
6
Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing.2019冠状病毒病的血栓预防：早期开始预防可能与最佳剂量同样重要。
Thromb Res. 2021 Aug;204:134-135. doi: 10.1016/j.thromres.2021.06.004. Epub 2021 Jun 16.
托珠单抗治疗新冠肺炎合并肺炎住院患者的疗效。
N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.
4
The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort.抗凝治疗对美国新型冠状病毒（COVID-19）肺炎患者临床结局的影响。
Thromb Res. 2021 Jan;197:65-68. doi: 10.1016/j.thromres.2020.10.031. Epub 2020 Nov 5.
5
The Use of Therapeutic-Dose Anticoagulation and Its Effect on Mortality in Patients With COVID-19: A Systematic Review.治疗剂量抗凝治疗在 COVID-19 患者中的应用及其对死亡率的影响：一项系统评价。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620960797. doi: 10.1177/1076029620960797.
6
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis.2019冠状病毒病患者发生静脉血栓栓塞的风险：一项系统评价和荟萃分析
Res Pract Thromb Haemost. 2020 Oct 13;4(7):1178-1191. doi: 10.1002/rth2.12439. eCollection 2020 Oct.
7
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.COVID-19 重症患者中中剂量与标准剂量预防性抗凝和他汀类药物治疗与安慰剂对照的研究：INSPIRATION/INSPIRATION-S 研究的原理和设计。
Thromb Res. 2020 Dec;196:382-394. doi: 10.1016/j.thromres.2020.09.027. Epub 2020 Sep 24.
8
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19.COVID-19 住院患者的抗凝、出血、死亡率和病理学。
J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826. doi: 10.1016/j.jacc.2020.08.041. Epub 2020 Aug 26.
9
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
10
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.新型冠状病毒肺炎中的高凝状态：发生率、病理生理学和管理。
Thromb Res. 2020 Oct;194:101-115. doi: 10.1016/j.thromres.2020.06.029. Epub 2020 Jun 20.